Printer Friendly

Kony AppPlatform Supports New EASE Application Providing Secure, Real-time Text, Photo, Video Updates to Patients' Families.

M2 PHARMA-August 30, 2017-Kony AppPlatform Supports New EASE Application Providing Secure, Real-time Text, Photo, Video Updates to Patients' Families

(C)2017 M2 COMMUNICATIONS

- EASE Applications has launched a new medical messaging application built on Austin, Texas-based enterprise mobility and digital applications company Kony, Inc.'s AppPlatform that enables hospital staff to securely share text, photo, and video updates to a patient's family, Kony said.

The EASE system was started in 2013 by a pediatric cardiac surgeon and two pediatric cardiac anesthesiologists, with a mission to reduce anxiety and provide transparency to nervous parents seeking information about their child's surgery and condition.

With security and privacy as a top priority, EASE Applications chose the Kony AppPlatform to help develop an enterprise-grade app that enables secure, HIPAA compliant communication of patient status updates, in order to protect private health information.

The cloud-based Kony AppPlatform also enables EASE Applications to scale its digital infrastructure as the company evolves.

EASE has been shown to benefit users at each point in the healthcare delivery process. In a recent study of over 8,000 families, 99% responded that EASE reduced their anxiety and 81% reported that the availability of EASE would influence their choice of hospital.

In addition, patient satisfaction scores increased by 6% for patients who used EASE compared to patients who did not use the application.

For doctors and nurses, EASE creates workflow efficiency and makes communication simple and secure without adding additional processes. For healthcare facilities, it generates in-app surveys that can be easily customized, giving the hospital the ability to collect the data it needs to track and improve patient satisfaction.

Kony is a cloud-based enterprise application and mobility solutions company, and mobile application development platform provider.

The company rapidly transforms ideas into innovative and secure omni-channel applications. Its cross-platform, low-code solution empowers organizations to develop and manage their own apps to better engage with their customers, partners, and employees.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Aug 30, 2017
Words:329
Previous Article:Merck Publishes Results of Outcomes Study of Anacetrapib for Treatment of Cardiovascular Disease.
Next Article:Castle Biosciences Study of Melanoma Test Demonstrates Improved Clinical Risk Assessment.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters